Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nana Gegechkori"'
Publikováno v:
Medical Clinics of North America. 101:1053-1073
Although many cancer survivors diagnosed with early-stage disease will outlive their cancer, they may continue to experience long-term and/or latent side effects due to cancer treatment. Many of these side effects are common and contribute to worse q
Publikováno v:
Breast (Edinburgh, Scotland). 47
Cardiovascular disease (CVD) is a leading cause of mortality in early-stage breast cancer survivors. Recent studies suggest that bisphosphonates may decrease CVD risk in older patients.This study sought to assess whether bisphosphonate use is associa
Publikováno v:
Breast cancer research and treatment. 176(2)
Despite lower incidence rates among black women and a national decline in breast cancer (BC) deaths, there is a widening gap in BC mortality rates between black and white women in the United States. A previous study evaluating data from 1992 to 1999
Publikováno v:
Breast Cancer Research and Treatment. 177:235-236
In the original publication of the article, under the Methods section, second paragraph, the sentence that reads as "We excluded 3047 patients … surgical treatment (see Fig. 1)" should read as "We excluded 3047 patients who did not identify as blac
Autor:
Fidelis C. Okoli, Kevin Tin, Roshan Srikanthan, Shawn Mathew, Ira Mayer, Dikshya Sharma, Rabin Rahmani, Prasun Shah, Daria Yunina, Nana Gegechkori, Kadirawel Iswara
Publikováno v:
American Journal of Gastroenterology. 113:S428-S429
Publikováno v:
Journal of Clinical Oncology. 35:116-116
116 Background: Multiple reasons have been cited for racial disparities in breast cancer survival, including differences in screening, tumor biology, estrogen receptor status, stage at presentation, treatment and comorbidities. Recent studies suggest